CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval.  CinCor’s focus is on cardiovascular, metabolic and kidney diseases.  CinCor Pharma, Inc. was founded by Jon Isaacsohn, M.D., and Catherine Pearce, DHSc, MBA, in 2018.

Biopharmaceuticals

Maina Bhaman

Maina  joined Sofinnova Partners in January 2018. Maina has a long track record as a successful healthcare investor. Prior to joining, she was Director of Healthcare Investment at Touchstone Innovations (formerly Imperial Innovations) in London (UK) since 2006. She has led or co-led numerous investm...